Concepedia

Clare Makumi

CM

Statistics

Publications

4

Citations

115

H-Index

4

Active since

2011

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

GlaxoSmithKline (United Kingdom)

Clare Makumi is an author at Research Triangle Park Foundation specializing in neurological assessment, pain management, and pre-clinical pharmacology.

Top concepts

Publications per year

2011–2014

4

Publications

4

A Randomized, Controlled Trial of Gabapentin Enacarbil in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy

Richard Rauck, Clare Makumi, Sherwyn Schwartz et al. · Pain Practice · 2012 · 58 citations

Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach

Amir Inamdar, Emilio Merlo‐Pich, Michelle Gee et al. · Journal of Psychopharmacology · 2014 · 29 citations

Long-term, Open-label Study of Once-daily Ropinirole Prolonged Release in Early Parkinson's Disease

Robert A. Hauser, Heinz Reichmann, Mark Lew et al. · International Journal of Neuroscience · 2011 · 15 citations

Long-term, open-label, safety study of once-daily ropinirole extended/prolonged release in early and advanced Parkinson's disease

Clare Makumi, Afsaneh Asgharian, Jeffrey J. Ellis et al. · International Journal of Neuroscience · 2014 · 13 citations

, , +21

1–4 of 4